AI evidence extraction

AI Consensus Validation in Biomedical Research: A Review, Conceptual Framework,and Future Directions

Tan Aik Kah · Medinformatics · 2026

AI-generated evidence extraction, verified across multiple analytical personas. Not a substitute for the peer-reviewed original.

9/10

Relevance

2/4

Quality (LMQS)

Evidence

Citations

0.00

FWCI

This is an AI analysis. Read the peer-reviewed original at the publisher: https://doi.org/10.47852/bonviewmedin62029207

Methodology & findings

Study design

Narrative and conceptual review with proof-of-concept case illustration.

Sample

N = 3, 9 groups

Primary method

This is a narrative review; no inferential statistical analyses were conducted on primary data. The proof-of-concept application used descriptive classification of convergence patterns: explicit agreement (identical or adjacent scores within one-point difference), implicit agreement (divergent scores but aligned qualitative rationale), and disagreement (two-point or greater divergence with incompatible rationale). Convergence metric calculated as percentage of dimensions exhibiting explicit agreement, classified as strong convergence (≥80%), moderate convergence (60-79%), or weak convergence (<60%). The authors note these thresholds are "intentionally heuristic and illustrative" rather than validated statistical decision rules. For proposed Phase 1 validation, authors suggest using intraclass correlation coefficients and Fleiss' kappa for reliability assessment.

Main result

This conceptual review proposes AI Consensus Validation (AICV), "a conceptual framework in which agreement among diverse LLMs—each trained on different data, developed by different institutions, and fine-tuned under distinct paradigms—is used to evaluate research abstracts across defined dimensions: clarity, novelty, scientific relevance, and conceptual soundness." The framework demonstrates that "when multiple independently developed LLMs converge in their qualitative assessment of a scientific idea, that consensus itself constitutes a novel form of epistemic signal." Through illustrative case analyses, the authors show that AICV "can produce interpretable, differential signals across varied research formats," with three biomedical abstracts exhibiting strong convergence (100%), strong convergence (100%), and weak convergence (50%) respectively.

Reports effect sizes.

Research paradigm

Interpretivist/constructivist with elements of critical realism; epistemologically grounded in social epistemology (Longino's epistemic diversity framework)

Author conclusions

The authors conclude: "The accelerating volume and complexity of biomedical research demand innovative approaches to validation that complement, rather than replace, the essential role of human expertise." They state that "AICV is not a speculative future technology but a feasible, implementable approach built on existing LLM capabilities. Its strength lies in epistemic diversity-the deliberate use of multiple, independently developed AI systems to simulate a form of machine-enabled critical dialogue." Further, they assert: "By introducing the concept of AICV, this work contributes a new theoretical lens through which AI-assisted research evaluation can be understood. Rather than optimizing individual model performance, the framework highlights the potential value of convergence among diverse AI systems as an indicator of epistemic robustness-an idea that has not yet been systematically explored in biomedical peer review."

Risk of bias

Selection bias in abstract curation (non-blinded selection); Epistemic homogeneity risk despite multi-model approach if all LLMs trained on similar corpora; Training data bias embedded in LLMs (gender, geographic, institutional biases); Publication bias in indexed literature used for model training; Single evaluator perspective in abstract selection for illustration; Training data bias: LLMs trained on historical corpora reflecting systemic inequities in publication, including gender, geographic, and institutional biases; Consensus masking convergent bias: Multiple models may agree because they share skewed training data, not because an idea is scientifically sound; Suppression of novelty and disruptive innovation: LLMs tend to favor ideas resembling existing literature, potentially penalizing paradigm-shifting research; Monolithic epistemic bias: Single-model approaches amplify specific biases embedded in that model's training data; Non-blinded abstract selection in proof-of-concept analysis: Authors selected abstracts non-blindly, introducing selection bias; Language and methodology bias: AI tools can undervalue research from low-and middle-income countries and penalize writing styles deviating from Western academic norms; Selection bias: abstracts were non-blinded and hand-selected rather than randomly sampled; Consensus bias: multiple models may converge due to shared training data rather than genuine intellectual merit, creating risk of 'convergent bias'; Epistemic homogeneity risk: despite emphasis on diversity, all three LLMs are commercial proprietary systems potentially sharing similar foundational training; Lack of human reviewer comparison: no validation against actual peer review outcomes; Publication bias: only published abstracts selected, excluding rejected manuscripts

Limitations

The authors explicitly state: "The small sample size (n = 3), non-blinded selection of abstracts, and use of only three LLMs constrain generalizability
Furthermore, the abstracts were evaluated in isolation, without comparison to human reviewer scores or eventual publication outcomes
These limitations underscore the need for the large-scale, controlled validation studies outlined in Section 8." Additionally, the illustrative results are "intended as proof-of-concept demonstrations rather than empirical validation." The paper also notes that "the thresholds are intentionally heuristic and illustrative, intended to demonstrate how convergence patterns may be interpreted in a conceptual framework rather than to represent validated statistical decision rules."

Open questions raised

Lack of systematic framework leveraging agreement among multiple independently developed LLMs as validation signal
Epistemic homogeneity in existing AI systems—most rely on single model
Fragmentation and lack of interoperable frameworks in current AI applications
Opacity and black-box nature of many AI assessment systems
Narrow technical validation versus holistic workflow impact assessment
Domain-specific validation across biomedical subfields

Data: "Deliverables from this phase include performance benchmarks, optimized scoring thresholds, and an open-access dataset to enable community validation and replication" [Phase 1 of proposed implementation roadmap, not yet available]Extracted from: pdfAgreement 56%

Explore related topics

AI Peer Review Peer Review Literature Review